https://www.newsworthy.ai/curated/lixte-biotechnology-s-pp2a-inhibitor-lb-100-aims-to-overcome-can/202628065
LIXTE Biotechnology's PP2A Inhibitor LB-100 Aims to Overcome Cancer Treatment Resistance |...
LIXTE Biotechnology is developing LB-100, a first-in-class PP2A inhibitor designed to enhance chemotherapy and immunotherapy effectiveness by disrupting cancer...
overcome cancerbiotechnologyinhibitorlbaims
https://openscience.ink/paper/lncrna-doxorubicin-resistance-cancer-networks-targeting
Targeting Long Noncoding RNA Networks to Overcome Cancer Resistance to Doxorubicin | studies,...
Feb 14, 2026 - Long noncoding RNAs (lncRNAs) may significantly influence doxorubicin (DOX) resistance across various cancers.
noncoding rnaovercome cancertargetinglongnetworks
https://www.gofundme.com/f/help-chrissy-overcome-cancer-and-financial-strain/donate?source=btn_donate
Donate to Help Chrissy Overcome Cancer and Financial Strain
donate to helpovercome cancerchrissyfinancialstrain
https://research.universityofgalway.ie/en/publications/targeting-the-ire1-xbp1-axis-to-overcome-endocrine-resistance-in--8/
Targeting the IRE1-XBP1 axis to overcome endocrine resistance in breast cancer: Opportunities and...
breast cancertargetingaxisovercomeendocrine